Vertex Pharmaceuticals (VRTX34.SA) Q1 2018 Earnings

31JanConfirmed
Q2 2017
Q3 2017
Q4 2017
Q1 2018
1.05
1.35
1.64
1.94

Details

Expected EPS
1.78332
Actual EPS
1.942545
Surprise EPS
0.16
Surprise Percent
+8.93%

Description

Vertex Pharmaceuticals (VRTX34.SA) has reported earnings of 1.942545 per share for Q1 2018.

0 Comments

Share your thoughts